Lyra Therapeutics (LYRA)
(Delayed Data from NSDQ)
$4.72 USD
-0.45 (-8.70%)
Updated Apr 26, 2024 03:59 PM ET
After-Market: $4.73 +0.01 (0.21%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/10/24 |
---|---|
Current Quarter | -0.26 |
EPS Last Quarter | -0.22 |
Last EPS Surprise | 33.33% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.04 |
Next Year | -1.17 |
EPS (TTM) | -1.26 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.40M | 0.40M | 1.62M | 1.61M |
# of Estimates | 2 | 2 | 2 | 2 |
High Estimate | 0.42M | 0.42M | 1.66M | 1.63M |
Low Estimate | 0.38M | 0.38M | 1.57M | 1.59M |
Year ago Sales | 0.41M | 0.46M | 1.56M | 1.62M |
Year over Year Growth Est. | -2.44% | -13.04% | 3.66% | -0.31% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.26 | -0.25 | -1.04 | -1.17 |
# of Estimates | 4 | 3 | 5 | 4 |
Most Recent Consensus | -0.28 | -0.28 | -1.21 | -1.30 |
High Estimate | -0.20 | -0.22 | -0.91 | -0.88 |
Low Estimate | -0.30 | -0.28 | -1.21 | -1.50 |
Year ago EPS | -0.44 | -0.33 | -1.23 | -1.04 |
Year over Year Growth Est. | 40.91% | 24.24% | 15.45% | -12.26% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 1 | 3 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 2 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.26 | -0.25 | -1.04 | -1.17 |
7 Days Ago | -0.26 | -0.25 | -1.04 | -1.17 |
30 Days Ago | -0.26 | -0.25 | -1.04 | -1.17 |
60 Days Ago | -0.30 | -0.26 | -1.07 | -1.23 |
90 Days Ago | -0.30 | -0.26 | -1.08 | -1.26 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.26 | -0.25 | -1.21 | -1.17 |
Zacks Consensus Estimate | -0.26 | -0.25 | -1.04 | -1.17 |
Earnings ESP | 0.00% | 0.00% | -16.35% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.22 | -0.27 | -0.33 | -0.44 | NA |
Estimate | -0.33 | -0.33 | -0.44 | -0.36 | NA |
Difference | 0.11 | 0.06 | 0.11 | -0.08 | 0.05 |
Surprise | 33.33% | 18.18% | 25.00% | -22.22% | 13.57% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more